In the face of market and regulatory pressures, oncology practices are embracing technology as a solution to enhance efficiencies,
increase profitability, and improve patient care. From adopting comprehensive electronic health record (EHR) platforms to
providing patients with medical record access and the ability to engage with their providers through online portals, oncology
practices are working to improve the quality of patient care. Opportunities for powerful insights into the oncology market
are also on the rise.
Challenges facing the community oncology practice include increasingly complex clinical decisions, larger patient loads, declining
reimbursement, and increased costs. With the growth of targeted therapies and companion diagnostics, as well as the proliferation
of new therapies available for several types of cancers, physicians are turning to technology to assist in treatment selection.
Targeted therapies have fueled most of the recent growth in the oncology market and "will dominate the top 20 cancer therapies
by 2017," according to a report from GBI Research. These market trends will require clinical systems that support physicians
in selecting the most appropriate treatments.
Another issue is declining revenue since the passage of the Medicare Modernization Act in 2003, as reimbursement shifted to
average sales price plus six percent for Medicare patients. According to ASCO, "Medicare patients make up 61 percent of new
cancer cases in the United States today and that proportion is expected to rise to 70 percent by 2030" leading to further
erosion of practice profitability stemming from lower reimbursement rates for Medicare. Drug costs are also on the rise; many
cancer treatments approved in the last two years came with a price tag north of $100,000; often, multiple therapies are concurrently
prescribed, compounding the cost of treatment. These dynamics will erode practice profitability, increasing the need for practices
to effectively capture charges, reduce drug loss, and maintain optimal inventory levels.
Finally, health reform will increase patient loads in a specialty that is already short of physicians: "An aging and growing
population, increasing numbers of cancer survivors, and slower growth in the supply of oncologists will result in a shortage
of 2,550 to 4,080 oncologists by 2020," according to ASCOs Journal of Oncology Practice, 2007. Physicians will have to turn to technology to support the increased patient demand and maintain optimal levels of patient
satisfaction and outcomes.
Adoption of health information technology will lead to improved efficiencies and assist with the challenges facing the community
oncologist. According to Information Week, "spending on electronic health records [will] grow from $2 billion in 2009 to $6 billion in 2015." The acceleration is the
result of federal programs created to support technology adoption with a goal to drive down the cost of care and improve patient
outcomes. The Health Information Technology for Economic and Clinical Health (HITECH) act that is part of the American Reinvestment
& Recovery Act provides up to $44,000 per provider for the adoption and "meaningful use" of a certified EHR system. The first
stage of the program launched in 2011 and the subsequent stages two and three are set to launch in 2014 and 2016, respectively.
The goal of the HITECH Meaningful Use program is to "promote the spread of electronic health records to improve healthcare
in the United States," according to http://www.healthit.gov/. The primary benefits include complete and accurate health information regardless of the setting, better access to health
information to improve outcomes, and boosting patient engagement.
Supporting patient treatment
Technology must support the most critical function of the oncology clinic: providing high quality care for patients. This
process is supported by a number of systems, including the EHR, inventory management system (IMS), practice management system
(PMS), and financial reporting system (FRS). These systems are connected by interfaces that facilitate the transfer of data
to support the patient treatment process from diagnosis, to treatment decision making, to claim submission and financial review,
ensuring efficiencies to increase revenue, decrease costs, and improve patient care. The patient demographic information is
entered into the PMS by the practice staff and is sent to all practice systems via the interface. The ability for the PMS
to send important data elements impacts the quality of the information that is generated from all other systems in the practice.
This information can then be extracted to provide insight into the patients' clinical and financial data.
Before treating the patient, the oncologist enters diagnosis and staging information along with any other relevant clinical
data required to create the treatment plan in the EHR. McKesson Specialty Health's iKnowMed EHR presents the physician with
the appropriate treatment regimens based on the patient's clinical factors. McKesson's collaboration with the National Comprehensive
Cancer Network to launch value pathways will allow oncologists to assess treatment options against evidence-based standards
at the point of care, enhancing the physician's ability to support increasingly complex clinical decisions. The EHR captures
rich clinical data that can also be used by brand managers to develop effective, targeted educational and marketing efforts.
Finally, this data can answer comparative effectiveness and other outcomes questions that support the overall value proposition
of brands within the marketplace.
Once the patient's order is reviewed and approved by the physician in the EHR, the order is sent to the IMS. McKesson Specialty
Health's Lynx Mobile, allows the user to match the EHR order with the item(s) pulled from the Lynx Mobile cabinet reducing
errors to optimize charge capture and practice revenue. In a study conducted in 2011, physician revenue from charge capture
was improved by $70,000 per physician annually after the implementation of Lynx Mobile. The system also provides a mechanism
for auto replenishment of drug and supplies, ensuring optimal inventory levels and reducing the capital required to run the
business, which is critical in the high drug cost, low reimbursement environment. The data captured in Lynx Mobile can be
leveraged to create intelligence for pharmaceutical-biotech companies, payers, and other healthcare stakeholders around product
utilization patterns providing insight into how their drugs are being prescribed and used.